|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:894-895
© 2002 The American Association for Thoracic Surgery
Editorials |
From the Mayo Clinic and Foundation, Rochester, Minn.
Received for publication April 30, 2002. Accepted for publication May 15, 2002. Address for reprints: Thoralf M. Sundt, MD, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905.
| The first 20% of the full text of this article appears below. |
| Introduction |
|---|
In this issue of the Journal, Moizumi and colleagues
1 from Sendai City Medical Center and Tohoku University present a thought-provoking analysis of their experience with what would be considered by most Western surgeons an iconoclastic approach to the management of intramural hematoma of the ascending aorta (IMH). Applying an algorithm of expectant (I would not call it conservative) therapy to 33 patients with this condition during a 9-year interval, these authors have acquired what is to my knowledge the largest reported single-center experience with this uncommon entity. Their results are excellent. They challenge us to rethink our approach to this condition.
In the authors' series, only patients with cardiac tamponade, impending rupture (described as hemodynamic instability or persistent pain), rupture, or progression of the IMH underwent surgery. All others were treated medically with aggressive antihypertensive therapy and bed rest. Nine of 33 patients underwent early surgery with what can only be considered a highly acceptable mortality rate of 11%, given that 5 of the 9 patients were in shock on admission and 3 underwent total arch replacement. Early mortality in the medical group was also low at 5% (P not significant). During the follow-up
Related Article
J. Thorac. Cardiovasc. Surg. 2002 124: 918-924.
This article has been cited by other articles:
![]() |
T. Kitai, S. Kaji, A. Yamamuro, T. Tani, K. Tamita, M. Kinoshita, N. Ehara, A. Kobori, M. Nasu, Y. Okada, et al. Clinical Outcomes of Medical Therapy and Timely Operation in Initially Diagnosed Type A Aortic Intramural Hematoma: A 20-Year Experience Circulation, September 15, 2009; 120(11_suppl_1): S292 - S298. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Baek, Y. Han Yoon, J. Taek Kim, and K. Ho Kim Recurrent type B intramural hematoma progressed into type A acute aortic dissection in a young otherwise healthy woman: are there unknown background factors? Interactive CardioVascular and Thoracic Surgery, April 1, 2007; 6(2): 255 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, T. Onitsuka, M. Yano, Y. Yano, M. Matsuyama, and K. Kojima Clinical analysis of acute type a intramural hematoma: comparison between two different pathophysiological types. Ann. Thorac. Surg., May 1, 2006; 81(5): 1587 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Moizumi, T. Komatsu, N. Motoyoshi, and K. Tabayashi Clinical features and long-term outcome of type A and type B intramural hematoma of the aorta J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |